Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Kallikrein 2 antibody (AA 1-223)

This Rabbit Polyclonal antibody specifically detects Kallikrein 2 in WB. It exhibits reactivity toward Human.
Catalog No. ABIN2611685

Quick Overview for Kallikrein 2 antibody (AA 1-223) (ABIN2611685)

Target

See all Kallikrein 2 (KLK2) Antibodies
Kallikrein 2 (KLK2)

Reactivity

  • 52
  • 7
  • 4
  • 3
  • 1
Human

Host

  • 47
  • 9
  • 1
  • 1
Rabbit

Clonality

  • 49
  • 9
Polyclonal

Conjugate

  • 33
  • 6
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Kallikrein 2 antibody is un-conjugated

Application

  • 31
  • 26
  • 22
  • 12
  • 8
  • 7
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Binding Specificity

    • 15
    • 10
    • 6
    • 6
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 1-223

    Specificity

    Human KLK2 / Kallikrein 2.

    Purification

    Affinity purified

    Immunogen

    Full length human KLK2, aa1-223 (NP_001002231.1).

    Type of Immunogen: Recombinant protein

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    PBS,  pH 7.2.

    Handling Advice

    Aliquot to avoid repeated freezing and thawing.

    Storage

    4 °C,-20 °C

    Storage Comment

    May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
  • Target

    Kallikrein 2 (KLK2)

    Alternative Name

    KLK2 / Kallikrein 2

    Background

    Name/Gene ID: KLK2
    Subfamily: Serine S1
    Family: Protease

    Synonyms: KLK2, Glandular kallikrein 2, Glandular kallikrein-1, HGK-1, Kallikrein 2, prostatic, Kallikrein-2, Kallikrein-related peptidase 2, KLK2A2, Tissue kallikrein-2

    Gene ID

    3817

    NCBI Accession

    NP_001002231

    Pathways

    Complement System
You are here:
Chat with us!